ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,854.79
-0.60%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Thermon Group Holdings Inc (THR)

  7. Thermon Group Holdings Inc (THR) Noticias

THR

Thermon (THR)

Thermon Group Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:THR
FechaHoraFuenteTítuloSímboloCompañía
16/05/202414:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:THRThermon Group Holdings Inc
15/05/202415:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:THRThermon Group Holdings Inc
11/03/202412:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:THRThermon Group Holdings Inc
14/02/202409:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:THRThermon Group Holdings Inc
01/02/202416:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:THRThermon Group Holdings Inc
01/02/202409:27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:THRThermon Group Holdings Inc
01/02/202405:45Edgar (US Regulatory)Form 8-K - Current reportNYSE:THRThermon Group Holdings Inc
21/06/202309:25Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:THRThermon Group Holdings Inc
21/06/202309:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:THRThermon Group Holdings Inc
05/06/202314:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:THRThermon Group Holdings Inc
31/05/202314:17Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:THRThermon Group Holdings Inc
25/05/202305:45Edgar (US Regulatory)Current Report Filing (8-k)NYSE:THRThermon Group Holdings Inc
14/02/202315:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:THRThermon Group Holdings Inc
09/02/202311:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:THRThermon Group Holdings Inc
06/02/202313:59Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NYSE:THRThermon Group Holdings Inc
03/11/202211:02Edgar (US Regulatory)Quarterly Report (10-q)NYSE:THRThermon Group Holdings Inc
26/05/202215:02Edgar (US Regulatory)Annual Report (10-k)NYSE:THRThermon Group Holdings Inc
23/02/202210:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:THRThermon Group Holdings Inc
04/02/202208:26Edgar (US Regulatory)Schedule 13gNYSE:THRThermon Group Holdings Inc
27/05/202116:14Edgar (US Regulatory)Amended Annual Report (10-k/a)NYSE:THRThermon Group Holdings Inc
09/04/202115:10Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:THRThermon Group Holdings Inc
18/11/202005:04Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:THRThermon Group Holdings Inc
27/07/202016:23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:THRThermon Group Holdings Inc
11/06/201900:30GlobeNewswireONCURIOUS NV Receives Project Grant from VLAIO to Progress its Pipeline of Next Generation Cancer ImmunotherapiesNYSE:THRThermon Group Holdings Inc
06/06/201912:00GlobeNewswireOxurion NV - Data from a Phase 1/2 Clinical Study evaluating THR-317 (anti-PlGF) for DME presented at 2019 FLORetina MeetingNYSE:THRThermon Group Holdings Inc
30/05/201914:12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NYSE:THRThermon Group Holdings Inc
08/05/201900:30GlobeNewswireOxurion NV : Oxurion NV Business Update - Q1 2019NYSE:THRThermon Group Holdings Inc
24/04/201900:30GlobeNewswireOxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 fo...NYSE:THRThermon Group Holdings Inc
04/04/201900:30GlobeNewswireOxurion NV announces full enrollment of its Phase 2 trial evaluating efficacy and safety of the combination of anti-PlGF (THR...NYSE:THRThermon Group Holdings Inc
07/03/201910:45GlobeNewswireOxurion NV Business Update - FY 2018NYSE:THRThermon Group Holdings Inc
 Showing the most relevant articles for your search:NYSE:THR

Su Consulta Reciente

NYSE
BAC
Bank of America
PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
USOTC
BNPQY
BNP Paribas (QX)
CCOM
SILVER
SILVER
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
NYSE
CVX
Chevron
CCOM
US30
US 30
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados